Literature DB >> 34993911

Betaine Ameliorates Depressive-Like Behaviors in Zinc Oxide Nanoparticles Exposed Mice.

Mohsen Jeyhoonabadi1, Samad Alimoahmmadi1, Shahin Hassanpour2, Mohammad Hashemnia1.   

Abstract

The aim of the current study was to determine protective effects of betaine on depressive-like behaviors in zinc oxide nanoparticles (ZnO NPs) exposed mice. Forty male mice randomly allocated into four experimental groups. Group 1 kept as control and groups 2-4 received oral administration of betaine (30 mg/kg), ZnO NPs (600 mg/kg), and ZnO NPs (600 mg/kg) 1 h after pre-administration of betaine (30 mg/kg) for 7 days, respectively. Then, forced swimming test (FST), tail suspension test (TST), open field test (OFT), and rotarod tests were done. Furthermore, serum malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GPx), and total antioxidant capacity (TAC) levels were determined. Hippocampal tissue samples were collected for histopathological assessment. According to the results, treatment with ZnO NPs significantly increased immobility time in the FST and TST (P<0.05). Betaine significantly decreased immobility time in the FST and TST (P<0.05). Pretreatment with betaine significantly decreased ZnO NPs-induced alterations in the FST and TST (P<0.05). The duration of staying on the rotarod and the numbers of crossings in the OFT significantly decreased in the mice that received ZnO NPs (P<0.05). These results were significantly improved in betaine+ZnO NPs treated mice as compared to the ZnO NPs group (P<0.05). Treatment with ZnO NPs significantly increased serum MDA level while decreased SOD and GPx compared to the control group (P<0.05). These changes were effectively ameliorated by pretreatment with betaine compared to the ZnO NPs group (P<0.05). No significant effect on serum TAC level was observed in all groups (P˃0.05). Administration of ZnO NPs decreased the thickness of hippocampus and pyramidal neurons in the hippocampal dentate gyrus (DG) and CA1 regions were sparsely arranged. Pretreatment with betaine caused an improvement in the histological features of the hippocampus when compared with ZnO NPs-treated mice. Taken together, these results suggest that betaine has protective role against ZnO NPs-induced toxicity in mice.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antioxidant status; Betaine; Depression; Hippocampus; Mice; Zinc oxide nanoparticles (ZnO NPs)

Mesh:

Substances:

Year:  2022        PMID: 34993911     DOI: 10.1007/s12011-021-03068-4

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   4.081


  38 in total

Review 1.  The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy.

Authors:  Tennyson L Doane; Clemens Burda
Journal:  Chem Soc Rev       Date:  2012-01-27       Impact factor: 54.564

2.  Exposure to Zinc Oxide Nanoparticles Induces Neurotoxicity and Proinflammatory Response: Amelioration by Hesperidin.

Authors:  Sabah Ansar; Manal Abudawood; Sherifa Shaker Hamed; Mukhtar M Aleem
Journal:  Biol Trace Elem Res       Date:  2016-06-14       Impact factor: 3.738

3.  Prenatal exposure to nanosized zinc oxide in rats: neurotoxicity and postnatal impaired learning and memory ability.

Authors:  Feng Xiaoli; Wu Junrong; Lai Xuan; Zhang Yanli; Wei Limin; Liu Jia; Shao Longquan
Journal:  Nanomedicine (Lond)       Date:  2017-03-21       Impact factor: 5.307

Review 4.  A review of nanoparticle functionality and toxicity on the central nervous system.

Authors:  Z Yang; Z W Liu; R P Allaker; P Reip; J Oxford; Z Ahmad; G Ren
Journal:  J R Soc Interface       Date:  2010-06-02       Impact factor: 4.118

5.  Anti-inflammatory effects of betaine on AOM/DSS‑induced colon tumorigenesis in ICR male mice.

Authors:  Dong Hwan Kim; Bokyung Sung; Yong Jung Kang; Jung Yoon Jang; Seong Yeon Hwang; Yujin Lee; Minjung Kim; Eunok Im; Jeong-Hyun Yoon; Cheol Min Kim; Hae Young Chung; Nam Deuk Kim
Journal:  Int J Oncol       Date:  2014-06-24       Impact factor: 5.650

Review 6.  A review of mammalian toxicity of ZnO nanoparticles.

Authors:  Rob J Vandebriel; Wim H De Jong
Journal:  Nanotechnol Sci Appl       Date:  2012-08-15

7.  Prenatal exposure to zinc oxide particles alters monoaminergic neurotransmitter levels in the brain of mouse offspring.

Authors:  Yuka Okada; Ken Tachibana; Shinya Yanagita; Ken Takeda
Journal:  J Toxicol Sci       Date:  2013       Impact factor: 2.196

Review 8.  Central nervous system toxicity of metallic nanoparticles.

Authors:  Xiaoli Feng; Aijie Chen; Yanli Zhang; Jianfeng Wang; Longquan Shao; Limin Wei
Journal:  Int J Nanomedicine       Date:  2015-07-03

Review 9.  Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling.

Authors:  Magdalena Jarosz; Magdalena Olbert; Gabriela Wyszogrodzka; Katarzyna Młyniec; Tadeusz Librowski
Journal:  Inflammopharmacology       Date:  2017-01-12       Impact factor: 4.473

10.  Neurotoxicity induced by zinc oxide nanoparticles: age-related differences and interaction.

Authors:  Lei Tian; Bencheng Lin; Lei Wu; Kang Li; Huanliang Liu; Jun Yan; Xiaohua Liu; Zhuge Xi
Journal:  Sci Rep       Date:  2015-11-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.